Invest in

Biotech Breakthroughs

15.9%
5.9%
0.3%

Feeling Better About Biotech

The next big cure for a complex, scary disease is unlikely to come from old-school pharma. It’s likely coming from biotech. Scientists, investors, and patients are all banking on the $93 billion biotech industry.[1] It’s outpaced Big Pharma in finding treatments for cancer, AIDS, multiple sclerosis, and other diseases. The FDA approved 43 drugs in 2012, a 20% jump from the previous year.[4] Big Pharma has responded by snapping up promising biotech and smaller pharmaceutical companies, at lofty valuations, with premiums for several public companies in excess of 50%.[2] In fact, 2013 was a big year for the biotech industry, with $29B in M&A deals through the 1st half of 2013.[3] This motif includes only biotech companies with at least two years of cash flow to help screen out companies at greater risk of losing money. See more
15.9%
5.9%
0.3%
Invest in Thematic Portfolios
Create your own customizable basket of up to 30 stocks or ETFs for just $9.95.
Motif Index 1 YR Return
Biotech Breakthroughs Benchmark
Open a Motif account to view and trade this basket of stocks for just $9.95:
Weight Segment & Stocks Symbol 1 MO / 1 YR Return
35.1% Cancer 17.8%
17.7% Amgen Inc. AMGN 9.2%
15.4% Celgene Corporation CELG 30.0%
1.0% 8xxxxxx 8xxxxxxx 8xxx 8xxx 88.8%
1.0% 8xxxxxxx 8xxxxxxxxxxxxxx 8xxx 8xxx 88.8%
17.7% Other Diseases 21.2%
5.7% 8xxxxxxxx 8xxxxxxxxxxxxxx 8xxx 8xxx 88.8%
5.1% 8xxxxxx 8xxxxxxxxxxxxxx 8xxx 8xxx 88.8%
4.4% 8xxxxx 8xxxxxxxxxxxxxx 8xxxxxxxxxxx 8xxx 88.8%
1.6% 8xxxxx 8xxxxxxxxxxx 8xxxxxxxxxx 8xxx 88.8%
1.0% 8xxxxxxx 8xxxxxxxxxx 8xxx 88.8%
17.1% Research & Diagnostics 16.9%
6.9% 8xxxxxxxx 8xx 8xxxxxxx 8xxx 8 88.8%
3.6% 8xxxxxxx 8xxx 8xxx 88.8%
3.1% 8xxxxxx 8xxxx 8xxxxxxxxxxx 8xxxxxxxxxxxx 8xx 88.8%
2.7% 8xxxxxxxxx 8xxx 8xxx 88.8%
0.8% 8xxxxxx 8xxxxxxxxxx 8xxx 88.8%
15.8% Autoimmune Disorders 8.4%
8.6% 8xxxxx 8xxx 8xxx 88.8%
3.0% 8xxxxxxx 8xxxxxxxxxxxxx 8xxx 8xxx 88.8%
2.8% 8xxxxx 8xxxxxxxxxx 8xxx 88.8%
1.4% 8xxxxxxxx 8x 8xxxx 8xx 8xxx 88.8%
13.3% Infectious Diseases 4.3%
13.3% Gilead Sciences Inc. GILD 4.3%
1.0% Cardiovascular 22.0%
1.0% 8xxxx 8xxxxxxxxxxxxxx 8xx 8xxx 88.8%

Quotes delayed 15 mins. Currently Sep 25, 2017 4:40:21 PM. Fields are marked with -- when data is unavailable.